trending Market Intelligence /marketintelligence/en/news-insights/trending/LabQXrYLWNSrtMF7coPNdg2 content esgSubNav
In This List

Vitamin Shoppe profit misses consensus by 33.9% in fiscal Q1

Blog

LCD Monthly Newsletter: September 2021

Blog

Industries Most and Least Impacted by COVID-19: A Market-Implied Probability of Default Perspective

Blog

Top 100 Banks: Capital Ratios Show Resilience to the Pandemic

Blog

Investment Banking Essentials Newsletter: October Edition


Vitamin Shoppe profit misses consensus by 33.9% in fiscal Q1

Vitamin Shoppe Inc. said its normalized net income for the fiscal first quarter ended April 1 was 38 cents per share, compared with the S&P Capital IQ consensus estimate of 57 cents per share.

EPS declined 46.1% year over year from 70 cents.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $8.7 million, a decrease of 50.4% from $17.5 million in the first quarter ended March 26, 2016.

The normalized profit margin dropped to 2.7% from 5.2% in the year-earlier period.

Total revenue fell 5.9% year over year to $316.9 million from $336.8 million, and total operating expenses decreased on an annual basis to $300.6 million from $306.6 million.

Reported net income fell 45.4% on an annual basis to $8.1 million, or 35 cents per share, from $14.8 million, or 59 cents per share.